Guselkumab Versus Risankizumab for Ulcerative Colitis: Real-World Comparison of Post-Induction Outcomes. (PubMed, Clin Gastroenterol Hepatol) - Sep 24, 2026 - No abstract available
Journal • Real-world evidence • Gastroenterology • Gastrointestinal Disorder • Immunology • Inflammation • Inflammatory Bowel Disease • Ulcerative Colitis
|
|
Alex D Carlin; Emma L McClure; Jessica R Allegretti; Karen M Kwaning; Mia E Silvestri; Rahul S Dalal
|